BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (1988) 61, 652
© 1988 British Institute of Radiology
doi: 10.1259/0007-1285-61-727-652-a

This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartnell, G. G.
Right arrow Articles by Hemingway, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartnell, G. G.
Right arrow Articles by Hemingway, A. P.

Contrast medium reactions—does Buscopan reduce them?

G. G. Hartnell * and A. P. Hemingway {dagger}

* Department of Radiology, Bristol Royal Infirmary, Bristol BS2 8HW {dagger} Academic Department of Radiology, Royal Hallamshire Hospital, Sheffield S10

This excerpt was created in the absence of an abstract.

A number of possible theories have been produced to account for adverse reactions to contrast media, including the theory that cholinergic pathways (Lalli, 1980) or cholinesterase inhibiting activity may be important (Manhire et al, 1984). With the introduction of digital subtraction angiography (DSA) it has been our practice to give the anticholinergic agent Buscopan (hyoscine butylbromide) to all patients in whom DSA images of the abdomen are required, to prevent bowel gas motion artefacts. It appeared to us that patients who received Buscopan experienced far fewer adverse reactions than those who did not.

Received for publication January 1, 1988.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 1988 by the British Institute of Radiology.